These 2 bargain dividend stocks could beat the FTSE 100 in 2017

Improving financial performance could allow these two stocks to outperform the FTSE 100 (INDEXFTSE:UKX).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Given that inflation is forecast to rise to 3% or more this year, a ‘bargain’ dividend stock may become an increasingly rare item. After all, investors are likely to seek dividends that are ahead of inflation in order to maintain a ‘real-terms’ income. Therefore, dividend shares may become increasingly expensive due to higher demand. At the present time, though, a number of dividend shares appear to offer excellent value for money. Here are two prime examples.

Improving performance

The recent results from Morrisons (LSE: MRW) show that the company’s new strategy is delivering improved performance. Not only has it resulted in the first year of positive like-for-like sales in around five years, debt levels are also being reduced. This means that the company’s financial strength is improving, which may lead to higher dividends in the long run.

Certainly, the current dividend yield of 2.6% is relatively low. However, Morrisons has scope to rapidly increase this over the medium term. It has a payout ratio of just 50%, which indicates that the dividend could increase by around 50% and still leave the business with sufficient capital to reinvest for future growth. And since the company’s bottom line is forecast to rise by 10% per annum for the next two years, dividends could rise by a similar amount in the near term.

Should you invest £1,000 in BT right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if BT made the list?

See the 6 stocks

Strategy changes, such as the reintroduction of the Safeway brand, and capital-light opportunities, such as online food delivery, could boost the company’s long-term profit growth yet further. In fact, a price-to-earnings growth (PEG) ratio of 1.9 doesn’t seem to factor in the company’s potential in future years. So now could be the right time to buy Morrisons for its FTSE 100-beating potential.

Defensive opportunity

While AstraZeneca’s (LSE: AZN) financial performance has been poor in recent years, it is expected to finally return to profit growth next year. Its bottom line is forecast to increase by 9% in 2018, which puts it on a relatively enticing PEG ratio of 1.1. Given the company’s defensive characteristics, this seems to be an attractive price to pay at a time when the FTSE 100 is trading close to its all-time high.

In fact, AstraZeneca could be a relatively low risk means of obtaining a high yield over the medium term. Its business model is less positively correlated to the wider economy than is the case for most FTSE 100 stocks, which means that it could offer lower volatility and risk reduction for a portfolio. Its dividend yield of 4.6% is covered 1.3 times by profit, which indicates it is sustainable at current levels. And with earnings growth just around the corner, dividends could begin to creep up after a handful of stagnant years.

Certainly, AstraZeneca’s turnaround plan is not complete. More investment will be required in order to develop a pipeline that can drive profitability higher over a sustained period. However, with a sound balance sheet and strong cash flow, the company has the potential to do so and beat the FTSE 100 in the process.

But this isn’t the only opportunity that’s caught my attention this week. Here are:

5 Shares for the Future of Energy

Investors who don’t own energy shares need to see this now.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.

While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.

Open this new report5 Shares for the Future of Energy — and discover:

  • Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
  • How to potentially get paid by the weather
  • Electric Vehicles’ secret backdoor opportunity
  • One dead simple stock for the new nuclear boom

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of AstraZeneca and Morrisons. The Motley Fool UK has recommended AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Businessman hand stacking up arrow on wooden block cubes
Investing Articles

5 AIM stocks to consider buying for the long term

We asked our writers to share their best AIM-listed stocks to consider buying, featuring five very different businesses.

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

Is the Rolls-Royce share price still undervalued in 2025?

After massive growth in the Rolls-Royce share price, Charlie Carman considers whether the FTSE 100 aerospace and defence stock is…

Read more »

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

How an investor could target a £43k lifelong passive income starting with just £5 a day

Harvey Jones says it's possible to build a high-and-rising passive income by investing small, regular sums in FTSE 100 shares.…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

£10,000 invested in Lloyds shares on 7 April is already worth…

After a dip in early April, Lloyds shares are back to their 30%+ year-to-date gain in 2025. And analysts are…

Read more »

Tariffs and Global Economic Supply Chains
US Stock

What I’d look to buy as the US stock market heads for the worst month since 1932

Jon Smith sifts through the US stock market to try and find some ideas that have fallen in value recently…

Read more »

Businessman hand stacking up arrow on wooden block cubes
Growth Shares

Prediction: I think £1,000 invested in this UK stock could double by 2030

Jon Smith runs through a FTSE 250 stock with a market cap just over £1bn that he feels has the…

Read more »

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

With £10k in savings, here’s how an investor could target a second income of £500 a month

£10k in savings could be the foundation needed towards a powerful second income. Our writer details some steps necessary to…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing For Beginners

£1k invested in the FTSE 100 on ‘Liberation Day’ is now worth…

Jon Smith talks about the volatility in the FTSE 100 in the weeks since the tariff announcements and flags up…

Read more »